NCT05293886

Brief Summary

Pelvic floor muscle training (PFMT) is indicated as a first-line treatment for stress urinary incontinence. PFMT aims to improve pelvic floor muscle strength, endurance and relaxation ability or a combination of these. PFMT is a structured and customized exercise program. Pelvic floor muscles work in synchronization with many muscles and pelvic floor muscle function is supported by synergistic muscles. Relationships between the functions of pelvic floor muscles and synergistic muscle groups have been reported in the literature. However, studies comparing the efficacy of PFMT and combined training of these muscles are limited and more studies are needed. Therefore the aim of this study is to compare the effects of isolated PFMT and functional PFMT in women with stress urinary incontinence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

March 4, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

March 15, 2022

Last Update Submit

March 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Symptom Severity and Impact of Incontinence on Life by International Urinary Incontinence Consultation Questionnaire Short Form

    International Urinary Incontinence Consultation Questionnaire Short Form will be used to evaluate the change in symptom severity and impact of incontinence on life. Score ranges are 1-5 (slight), 6- 2 (moderate), 13-18 (severe) and 19-21 (very severe). Lower scores mean a better outcome for this questionnaire form.

    Change in International Urinary Incontinence Consultation Questionnaire Short Form score from baseline to end of 8th week

Secondary Outcomes (4)

  • Incontinence Severity by 1-hour pad test

    Change in incontinence severity from baseline to end of 8th week.

  • The Impact of Incontinence on Quality of Life by King Health Questionnaire

    Change in King Health Questionnaire score from baseline to end of 8th week.

  • Participant's Perception of Symptom Severity by Patient Global Impression of Severity Scale

    Change in Patient Global Impression of Severity Scale score from baseline to end of 8th week.

  • Participant's Perception of Recovery by Patient Global Impression of Change Scale

    Change in Patient Global Impression of Change Scale score from baseline to end of 8th week.

Study Arms (2)

Classical Pelvic Floor Muscle Training

ACTIVE COMPARATOR

In the first 2 weeks of classical pelvic floor muscle training, individuals will perform 3 sets of 10 maximal voluntary pelvic floor muscle contraction exercises and 20 submaximal voluntary pelvic floor muscle contraction exercises per day. In every 2-week control, the number of sets will be increased by one set.

Other: Classical Pelvic Floor Muscle Training

Functional Pelvic Floor Muscle Training

EXPERIMENTAL

Functional pelvic floor muscle training will be started with 3 exercises (toe tap, bridge and clamshall exercises), each exercise will be performed with 1 set and 30 repetitions. In every 2-week control, the number of exercises will be increased by one. Cat-cow exercise will be added at 3-4th weeks, squats will be added at 5-6th weeks, and lunges will be added at 7-8th weeks.

Other: Functional Pelvic Floor Muscle Training

Interventions

In the first 2 weeks of classical pelvic floor muscle training, individuals will perform 3 sets of 10 maximal voluntary pelvic floor muscle contraction exercises and 20 submaximal voluntary pelvic floor muscle contraction exercises per day. In every 2-week control, the number of sets will be increased by one set.

Classical Pelvic Floor Muscle Training

Functional pelvic floor muscle training will be started with 3 exercises (toe tap, bridge and clamshall exercises), each exercise will be performed with 1 set and 30 repetitions. In every 2-week control, the number of exercises will be increased by one. Cat-cow exercise will be added at 3-4th weeks, squats will be added at 5-6th weeks, and lunges will be added at 7-8th weeks.

Functional Pelvic Floor Muscle Training

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering from stress urinary incontinence or SUI predominant Mixed Urinary Incontinence according to the 3 Incontinence Questionnaire (3IQ)
  • Body mass index \<35 kg/m²
  • Individuals over the age of 18 (with a Mini Mental Test score ≥ 24 for individuals over the age of 65)

You may not qualify if:

  • Patients with pure urge incontinence, urge predominant mixed urinary incontinence or neurogenic bladder
  • Pregnancy or suspected of pregnancy
  • Those who have given birth in the last 1 year
  • Being virgin
  • Those who have had abdomino-pelvic surgery in the last 6 months, and/or those who have received abdomino-pelvic radiotherapy
  • Those with urinary tract infection, recurrent urinary tract infection, diagnosis of interstitial cystitis
  • Any orthopedic problem that will hinder exercise
  • Patients over 65 years of age with a mini mental test score \< 24
  • Patients with Pelvic Organ Prolapse grade ≥ Stage 2
  • Those who have received treatment for urinary incontinence in the last 6 months
  • Those who have uncontrolled diabetes and hypertension, severe systemic disease
  • Those who have a neurological disease that will affect the urinary system
  • Those who have started a new drug that will affect bladder functions in the last 1 month
  • The strength of the pelvic floor muscles in digital examination is \<2 according to the Modified Oxford Scale score.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Berna Tokmak

Ankara, 06100, Turkey (Türkiye)

Location

Related Publications (10)

  • Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, Berghmans B, Bortolini M, Dumoulin C, Gomes M, McClurg D, Meijlink J, Shelly E, Trabuco E, Walker C, Wells A. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Neurourol Urodyn. 2017 Feb;36(2):221-244. doi: 10.1002/nau.23107. Epub 2016 Dec 5.

    PMID: 27918122BACKGROUND
  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.

    PMID: 1202204BACKGROUND
  • Gungen C, Ertan T, Eker E, Yasar R, Engin F. [Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population]. Turk Psikiyatri Derg. 2002 Winter;13(4):273-81. Turkish.

    PMID: 12794644BACKGROUND
  • Jorgensen L, Lose G, Andersen JT. One-hour pad-weighing test for objective assessment of female urinary incontinence. Obstet Gynecol. 1987 Jan;69(1):39-42.

    PMID: 3796918BACKGROUND
  • Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322-30. doi: 10.1002/nau.20041.

    PMID: 15227649BACKGROUND
  • Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997 Dec;104(12):1374-9. doi: 10.1111/j.1471-0528.1997.tb11006.x.

    PMID: 9422015BACKGROUND
  • Kaya S, Akbayrak T, Toprak Celenay S, Dolgun A, Ekici G, Beksac S. Reliability and validity of the Turkish King's Health Questionnaire in women with urinary incontinence. Int Urogynecol J. 2015 Dec;26(12):1853-9. doi: 10.1007/s00192-015-2786-6. Epub 2015 Jul 26.

    PMID: 26209953BACKGROUND
  • Fischer MC, Huckabay C, Nitti VW. The male perineal sling: assessment and prediction of outcome. J Urol. 2007 Apr;177(4):1414-8. doi: 10.1016/j.juro.2006.11.061.

    PMID: 17382743BACKGROUND
  • Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003 Jul;189(1):98-101. doi: 10.1067/mob.2003.379.

    PMID: 12861145BACKGROUND
  • Hay-Smith EJC, Starzec-Proserpio M, Moller B, Aldabe D, Cacciari L, Pitangui ACR, Vesentini G, Woodley SJ, Dumoulin C, Frawley HC, Jorge CH, Morin M, Wallace SA, Weatherall M. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD009508. doi: 10.1002/14651858.CD009508.pub2.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Serap Özgül, Prof

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 15, 2022

First Posted

March 24, 2022

Study Start

November 15, 2021

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

March 4, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations